CV Lattes
Secretaria da Saúde (São Paulo - Estado). Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da USP (HCMRP). Hemocentro de Ribeirão Preto (Institutional affiliation from the last research proposal) Birthplace: Brazil
bachelor's at Ciências Biológicas - Modalidade Médica from Centro Universitário Barão de Mauá (2007) and master's at Imunologia Básica e Aplicada from Faculdade de Medicina de Ribeirão Preto - USP (2010). Has experience in Immunology, focusing on Immunology, acting on the following subjects: linhaça, quimiotaxia, eicosanóides, inflamação and bone marrow-derived macrophages. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
It has been estimated that worldwide more than 20 million people are infected by HTLV-1. In Brazil, there are approximately 2.5 million carriers of this virus, which places the country on the first position regarding the absolute number of infected individuals. HTLV-1 is associated with two main clinical diseases: i) adult T-cell (ATLL) leukemia / lymphoma; and ii) progressive myelopathy …
Human T cell lymphotropic virus type 1 (HTLV-1) was the first human retrovirus to be discovered. Approximately, 10 - 20 million people are infected with HTLV-1 worldwide, and in Brazil, there are about 2.5 million HTLV-1-carriers. The main HTLV-1-associated diseases are the HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and the adult T cell leukemia/lymphoma (ATL). Cu…
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |